Literature DB >> 17172589

IBD5 is associated with an extensive complicated Crohn's disease feature: implications from genotype-phenotype analysis.

S Brescianini, T Trinh, M Stoll, S Schreiber, J D Rioux, M J Daly.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17172589      PMCID： PMC1856659          DOI： 10.1136/gut.2006.102723

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.

Authors:  J D Rioux; M J Daly; M S Silverberg; K Lindblad; H Steinhart; Z Cohen; T Delmonte; K Kocher; K Miller; S Guschwan; E J Kulbokas; S O'Leary; E Winchester; K Dewar; T Green; V Stone; C Chow; A Cohen; D Langelier; G Lapointe; D Gaudet; J Faith; N Branco; S B Bull; R S McLeod; A M Griffiths; A Bitton; G R Greenberg; E S Lander; K A Siminovitch; T J Hudson
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

Review 2.  Genotypes and phenotypes in Crohn's disease: do they help in clinical management?

Authors:  C Gasche; P Grundtner
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.

Authors:  O Palmieri; A Latiano; R Valvano; R D'Incà; M Vecchi; G C Sturniolo; S Saibeni; F Peyvandi; F Bossa; C Zagaria; A Andriulli; M Devoto; V Annese
Journal:  Aliment Pharmacol Ther       Date:  2006-02-15       Impact factor: 8.171

4.  The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.

Authors:  Colin L Noble; Elaine R Nimmo; Hazel Drummond; Gwo-Tzer Ho; Albert Tenesa; Linda Smith; Norman Anderson; Ian D R Arnott; Jack Satsangi
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

5.  Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.

Authors:  Séverine Vermeire; Marie Pierik; Tibor Hlavaty; Greet Claessens; Nele van Schuerbeeck; Sofie Joossens; Marc Ferrante; Liesbet Henckaerts; Mirjam Bueno de Mesquita; Robert Vlietinck; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

6.  Contribution of IBD5 locus to clinical features of IBD patients.

Authors:  Anna Latiano; O Palmieri; Rossella M Valvano; Renata D'Incà; Maurizio Vecchi; Angelo Ferraris; Giacomo C Sturniolo; Luisa Spina; Giovanni Lombardi; Bruno Dallapiccola; Angelo Andriulli; Marcella Devoto; Vito Annese
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

7.  Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31.

Authors:  A Armuzzi; T Ahmad; K-L Ling; A de Silva; S Cullen; D van Heel; T R Orchard; K I Welsh; S E Marshall; D P Jewell
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

8.  IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis.

Authors:  Cosmas Giallourakis; Monika Stoll; Katie Miller; Jochen Hampe; Eric S Lander; Mark J Daly; Stefan Schreiber; John D Rioux
Journal:  Am J Hum Genet       Date:  2003-05-29       Impact factor: 11.025
  8 in total
  3 in total

1.  Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis.

Authors:  V Valatas; J He; A Rivollier; G Kolios; K Kitamura; B L Kelsall
Journal:  Mucosal Immunol       Date:  2012-11-14       Impact factor: 7.313

Review 2.  Role of genetics in pediatric inflammatory bowel disease.

Authors:  David T Okou; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

3.  Natural Selection and Functional Potentials of Human Noncoding Elements Revealed by Analysis of Next Generation Sequencing Data.

Authors:  Pankaj Jha; Dongsheng Lu; Shuhua Xu
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.